SER SERINA THERAP
SERINA THERAP (SER) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $97.5K.
Where they traded
Last open-market purchase: July 7, 2026 , by Brannan Stephen K. .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Brannan Stephen K. | Director | Buy | 1,000 | $2.03 | $2.0K | 1,000 | |
| WILSON KAREN J | Director | Buy | 5,000 | $1.77 | $8.9K | 10,100 | |
| WILSON KAREN J | Director | Buy | 5,100 | $1.75 | $8.9K | 5,100 | |
| WILSON KAREN J | Director | Buy | 10,000 | $1.93 | $19.3K | 20,000 | |
| Venkatesan Jay | Director | Buy | 589 | $1.78 | $1.0K | 589 | |
| WILSON KAREN J | Director | Buy | 10,000 | $1.77 | $17.7K | 10,000 | |
| Marshall Richard Peter | Director | Buy | 12,183 | $1.65 | $20.1K | 12,183 | |
| Moreadith Randall | Chief Scientific Officer | Sell | 6,500 | $2.86 | $18.6K | None left | |
| Moreadith Randall | Chief Scientific Officer | Sell | 39,000 | $2.50 | $97.5K | None left | |
| Moreadith Randall | Chief Scientific Officer | Sell | 6,500 | $3.03 | $19.7K | None left | |
| Moreadith Randall | Chief Scientific Officer | Sell | 6,500 | $3.57 | $23.2K | None left | |
| Moreadith Randall | Chief Scientific Officer | Sell | 2,500 | $2.95 | $7.4K | None left | |
| Moreadith Randall | Chief Scientific Officer | Sell | 2,000 | $3.00 | $6.0K | None left | |
| Moreadith Randall | Chief Scientific Officer | Sell | 2,000 | $3.07 | $6.1K | None left | |
| Moreadith Randall | Chief Scientific Officer | Sell | 1,084 | $2.50 | $2.7K | None left | |
| Moreadith Randall | Chief Scientific Officer | Sell | 5,416 | $2.50 | $13.5K | None left | |
| Moreadith Randall | Chief Scientific Officer | Sell | 13,000 | $2.69 | $35.0K | None left | |
| Moreadith Randall | Chief Scientific Officer | Sell | 4,100 | $2.60 | $10.7K | None left | |
| Moreadith Randall | Chief Scientific Officer | Sell | 5,673 | $2.67 | $15.2K | None left | |
| Moreadith Randall | Chief Scientific Officer | Sell | 3,227 | $2.96 | $9.6K | None left | |
| Moreadith Randall | Chief Scientific Officer | Sell | 1,700 | $3.26 | $5.5K | None left | |
| Moreadith Randall | Chief Scientific Officer | Sell | 3,555 | $3.24 | $11.5K | None left | |
| Moreadith Randall | Chief Scientific Officer | Sell | 645 | $3.35 | $2.2K | None left | |
| Moreadith Randall | Chief Scientific Officer | Sell | 600 | $3.31 | $2.0K | None left | |
| Moreadith Randall | Chief Scientific Officer | Sell | 5,000 | $3.52 | $17.6K | None left | |
| Moreadith Randall | Chief Scientific Officer | Sell | 1,500 | $3.91 | $5.9K | None left | |
| Moreadith Randall | Chief Scientific Officer | Sell | 5,965 | $3.90 | $23.3K | 5,965 −50% of holding | |
| Moreadith Randall | Chief Scientific Officer | Sell | 535 | $3.94 | $2.1K | None left | |
| Moreadith Randall | Chief Scientific Officer | Sell | 6,500 | $3.75 | $24.4K | None left | |
| Moreadith Randall | Chief Scientific Officer | Sell | 6,500 | $4.10 | $26.7K | None left | |
| Moreadith Randall | Chief Scientific Officer | Sell | 3,398 | $4.24 | $14.4K | None left | |
| Moreadith Randall | Chief Scientific Officer | Sell | 3,102 | $4.40 | $13.6K | None left | |
| Moreadith Randall | Chief Scientific Officer | Sell | 5,551 | $4.96 | $27.5K | None left | |
| Moreadith Randall | Chief Scientific Officer | Sell | 949 | $5.19 | $4.9K | None left | |
| Moreadith Randall | Chief Scientific Officer | Sell | 6,500 | $4.97 | $32.3K | None left | |
| Moreadith Randall | Chief Scientific Officer | Sell | 4,326 | $5.20 | $22.5K | None left |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.